Contact Aspiration Equals Stent Retriever for Acute Stroke Care
|
By HospiMedica International staff writers Posted on 07 Mar 2017 |

Image: The Penumbra direct aspiration catheter (Photo courtesy of Penumbra).
The direct aspiration, first pass technique (ADAPT) for clearing large-vessel ischemic strokes is as safe and successful for reperfusion as a stent retriever, according to a new study.
Researchers at Foch Hospital, Lille University of Science and Technology, and other institutions conducted the prospective ADAPT versus StEnt Retriever (ASTER) study to compare the two strategies for treating patients with ischemic anterior circulation stroke secondary to large vessel occlusion (LVO). Patients who met criteria on imaging were randomized to either direct contact aspiration (192 patients), or to mechanical thrombectomy with a stent retriever (189 patients) as first-line treatment, with a switch to other therapy allowed after three failed attempts.
The primary outcome was successful recanalization, with secondary outcomes including initial successful use of the assigned treatment technique, overall procedural times, complications, and modified Rankin Scale (mRS) at three month. The results showed that the rate of successful recanalization at the end of the treatment was 85.4% with ADAPT using the Penumbra stroke system aspiration catheter, compared to 83.1% with stent retriever as the first-line strategy.
In addition, 63% of the patients treated with ADAPT achieved the three month secondary endpoints, compared to 67.7% of the patients treated with stent retrievers. All safety endpoints, including new embolization or infarct, arterial perforation, arterial dissection, vasospasm, and intracranial or subarachnoid hemorrhage were similar between treatment strategies. The study was presented at the International Stroke Conference, held during February 2017 in Houston (TX, USA).
“There are no significant difference in revascularization rate and safety using either thrombectomy technique with Penumbra aspiration and stent retrievers for acute ischemic stroke patients with large vessel occlusions," said lead author Bertrand Lapergue, MD, PhD, of the stroke center at Foch Hospital. “The broad eligibility criteria achieved make the ASTER results generalizable to the majority of stroke patients with large vessel occlusions.”
Stent retrievers are deployed in an occluded vessel and are temporarily expanded into the body of a thrombus in order to recanalize the vessel, allowing for reperfusion of ischemic sites and causing the thrombus to be partially entangled within the stent. Thrombectomy is then performed by retracting the stent.
Researchers at Foch Hospital, Lille University of Science and Technology, and other institutions conducted the prospective ADAPT versus StEnt Retriever (ASTER) study to compare the two strategies for treating patients with ischemic anterior circulation stroke secondary to large vessel occlusion (LVO). Patients who met criteria on imaging were randomized to either direct contact aspiration (192 patients), or to mechanical thrombectomy with a stent retriever (189 patients) as first-line treatment, with a switch to other therapy allowed after three failed attempts.
The primary outcome was successful recanalization, with secondary outcomes including initial successful use of the assigned treatment technique, overall procedural times, complications, and modified Rankin Scale (mRS) at three month. The results showed that the rate of successful recanalization at the end of the treatment was 85.4% with ADAPT using the Penumbra stroke system aspiration catheter, compared to 83.1% with stent retriever as the first-line strategy.
In addition, 63% of the patients treated with ADAPT achieved the three month secondary endpoints, compared to 67.7% of the patients treated with stent retrievers. All safety endpoints, including new embolization or infarct, arterial perforation, arterial dissection, vasospasm, and intracranial or subarachnoid hemorrhage were similar between treatment strategies. The study was presented at the International Stroke Conference, held during February 2017 in Houston (TX, USA).
“There are no significant difference in revascularization rate and safety using either thrombectomy technique with Penumbra aspiration and stent retrievers for acute ischemic stroke patients with large vessel occlusions," said lead author Bertrand Lapergue, MD, PhD, of the stroke center at Foch Hospital. “The broad eligibility criteria achieved make the ASTER results generalizable to the majority of stroke patients with large vessel occlusions.”
Stent retrievers are deployed in an occluded vessel and are temporarily expanded into the body of a thrombus in order to recanalize the vessel, allowing for reperfusion of ischemic sites and causing the thrombus to be partially entangled within the stent. Thrombectomy is then performed by retracting the stent.
Latest Surgical Techniques News
- Novel Endoscopy Technique Provides Access to Deep Lung Tumors
- New Study Findings Could Halve Number of Stent Procedures
- Breakthrough Surgical Device Redefines Hip Arthroscopy
- Automated System Enables Real-Time "Molecular Pathology" During Cancer Surgery
- Groundbreaking Procedure Combines New Treatments for Liver Tumors
- Ablation Reduces Stroke Risk Associated with Atrial Fibrillation
- Optical Tracking Method Identifies Target Areas in Robot-Assisted Neurosurgery
- General Anesthesia Improves Post-Surgery Outcomes for Acute Stroke Patients
- Drug-Coated Balloons Can Replace Stents Even in Larger Coronary Arteries
- Magnetic Kidney Stone Retrieval Device Outperforms Ureteroscopic Laser Lithotripsy
- Absorbable Skull Device Could Replace Traditional Metal Implants Used After Brain Surgery
- Magic Silicone Liquid Powered Robots Perform MIS in Narrow Cavities
- 'Lab-on-a-Scalpel' Provides Real-Time Surgical Insights for POC Diagnostics in OR
- Biodegradable Brain Implant Prevents Glioblastoma Recurrence
- Tiny 3D Printer Reconstructs Tissues During Vocal Cord Surgery
- Minimally Invasive Procedure for Aortic Valve Disease Has Similar Outcomes as Surgery
Channels
Critical Care
view channel
Nanogel Technology Almost 100% Effective in Destroying Drug-Resistant Bacteria Within Hours
Antibiotic resistance is one of the most serious global health threats, driven by bacteria that evade treatment and form protective biofilms that shield them from drugs. Pathogens such as Pseudomonas aeruginosa,... Read more
Wearable Ultrasound Sensor Delivers Noninvasive Treatment Without Surgery
Wearable ultrasound devices have long struggled with low acoustic power and poor structural stability, limiting their use in high-resolution imaging and therapeutic applications. Conventional flexible... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







